Media

Spruce Biosciences Provides Clinical Program Updates and Outlook for 2024

Vicore Reports Positive Results for the Pivotal Study of its Digital Therapy for Patients with Pulmonary Fibrosis

Vicore Confirms IPF Development Program on Track and Provides Early-Stage Pipeline Updates

Vicore Appoints Leading Respiratory Medicine Developer Dr. Bertil Lindmark MD, PhD, as Chief Medical Officer

Oncopedtides – Update on the Type II application process

First In Vivo CAR-M Lead Candidate Nominated Under Carisma-Moderna Collaboration

BONESUPPORT receives MDR certification for CERAMENT® BONE VOID FILLER and CERAMENT® V

Hemab Therapeutics Announces First Patient Dosed in Phase 2 Clinical Study Investigating HMB-001 for the Treatment of Glanzmann Thrombasthenia

Ariceum Therapeutics announces granting of US and Canadian patents for its Gallium-68 radiopharmaceutical production kit

Carisma Therapeutics Announces FDA Clearance of IND Application for CT-0525, a Novel HER2-Targeting CAR-Monocyte